PP
NXTC icon

PDT Partners’s NextCure NXTC Stock Holding History

PDT Partners’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,915
Closed -$155K – 974
2021
Q3 		$155K Sell
1,915
-3,199
-63% -$281K 0.01% 711
2021
Q2 		$493K Sell
5,114
-463
-8% -$47.4K 0.03% 519
2021
Q1 		$670K Sell
5,577
-2,245
-29% -$325K 0.05% 455
2020
Q4 		$1.02M Sell
7,822
-11,146
-59% -$1.44M 0.07% 321
2020
Q3 		$2M Buy
18,968
+17,937
+1,740% +$2.21M 0.13% 217
2020
Q2 		$265K Buy
1,031
+391
+61% +$149K 0.02% 545
2020
Q1 		$284K Buy
+640
New +$342K 0.02% 488

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PDT Partners's NXTC Position: Q4 2021 in Review

PDT Partners sold out of NextCure (NXTC) in Q4 2021, closing a stake of 1,915 shares — an estimated $155K sold.

PDT Partners first reported a position in NXTC in Q1 2020 and held it in 7 quarters. The position peaked at $2M in Q3 2020. 71 funds tracked by Wall St. Rank hold NXTC as of Q4 2021.

  • PDT Partners reported no remaining NextCure position as of Q4 2021 after selling out during the quarter.
  • PDT Partners sold 1,915 NextCure shares in Q4 2021, an estimated $155K.
  • PDT Partners first reported a position in NextCure in Q1 2020 and held it in 7 quarters.
  • PDT Partners's NextCure position peaked at $2M in Q3 2020.
  • 71 funds tracked by Wall St. Rank held NextCure as of Q4 2021.

Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.